Overview

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects

Status:
Completed

Trial end date:
2017-03-22

Target enrollment:

Participant gender:

Summary

The primary objective of this study was to evaluate the adhesion performance of ZTlido® (lidocaine topical system) 1.8% compared to adhesion performance for Lidoderm® (lidocaine patch 5%) and Versatis® (lidocaine medicated plaster 5%).

Phase:

Phase 1

Details

Lead Sponsor:

Scilex Pharmaceuticals, Inc.

Treatments:

Lidocaine